6dkv

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (06:08, 11 October 2023) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 1: Line 1:
==Directed evolutionary changes in Kemp Eliminase KE07 - Crystal 21 round 5==
==Directed evolutionary changes in Kemp Eliminase KE07 - Crystal 21 round 5==
-
<StructureSection load='6dkv' size='340' side='right' caption='[[6dkv]], [[Resolution|resolution]] 1.89&Aring;' scene=''>
+
<StructureSection load='6dkv' size='340' side='right'caption='[[6dkv]], [[Resolution|resolution]] 1.89&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[6dkv]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6DKV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6DKV FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[6dkv]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6DKV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6DKV FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6VP:5-NITRO-2-OXIDANYL-BENZENECARBONITRILE'>6VP</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.89&#8491;</td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6dkv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6dkv OCA], [http://pdbe.org/6dkv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6dkv RCSB], [http://www.ebi.ac.uk/pdbsum/6dkv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6dkv ProSAT]</span></td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6VP:5-NITRO-2-OXIDANYL-BENZENECARBONITRILE'>6VP</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6dkv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6dkv OCA], [https://pdbe.org/6dkv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6dkv RCSB], [https://www.ebi.ac.uk/pdbsum/6dkv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6dkv ProSAT]</span></td></tr>
</table>
</table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Developments in computational chemistry, bioinformatics, and laboratory evolution have facilitated the de novo design and catalytic optimization of enzymes. Besides creating useful catalysts, the generation and iterative improvement of designed enzymes can provide valuable insight into the interplay between the many phenomena that have been suggested to contribute to catalysis. In this work, we follow changes in conformational sampling, electrostatic preorganization, and quantum tunneling along the evolutionary trajectory of a designed Kemp eliminase. We observe that in the Kemp Eliminase KE07, instability of the designed active site leads to the emergence of two additional active site configurations. Evolutionary conformational selection then gradually stabilizes the most efficient configuration, leading to an improved enzyme. This work exemplifies the link between conformational plasticity and evolvability and demonstrates that residues remote from the active sites of enzymes play crucial roles in controlling and shaping the active site for efficient catalysis.
 +
 +
The evolution of multiple active site configurations in a designed enzyme.,Hong NS, Petrovic D, Lee R, Gryn'ova G, Purg M, Saunders J, Bauer P, Carr PD, Lin CY, Mabbitt PD, Zhang W, Altamore T, Easton C, Coote ML, Kamerlin SCL, Jackson CJ Nat Commun. 2018 Sep 25;9(1):3900. doi: 10.1038/s41467-018-06305-y. PMID:30254369<ref>PMID:30254369</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 6dkv" style="background-color:#fffaf0;"></div>
 +
 +
==See Also==
 +
*[[Kemp eliminase|Kemp eliminase]]
 +
== References ==
 +
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Carr, P D]]
+
[[Category: Large Structures]]
-
[[Category: Hong, N S]]
+
[[Category: Synthetic construct]]
-
[[Category: Jackson, C J]]
+
[[Category: Carr PD]]
-
[[Category: De novo protein]]
+
[[Category: Hong N-S]]
-
[[Category: Directed evolution]]
+
[[Category: Jackson CJ]]
-
[[Category: Ke07]]
+
-
[[Category: Kemp eliminase]]
+
-
[[Category: Lyase]]
+

Current revision

Directed evolutionary changes in Kemp Eliminase KE07 - Crystal 21 round 5

PDB ID 6dkv

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools